The agency said in a letter to the director of BARDA that the authorization was for patients unable to participate in clinical trials. However, there is scant evidence demonstrating that the drugs, hydroxychloroquine and chloroquine, are effective against Covid-19.

LEAVE A REPLY

Please enter your comment!
Please enter your name here